AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22503302 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin E on alternate days
Number of subjects: 14236
Study 22503302 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of vitamin C daily
Number of subjects: 14236
Study 22503302 — intervention group
Group type: COMPARATOR
Intervention: Placebo for vitamin E
Number of subjects: 14236
Study 22503302 — intervention group
Group type: COMPARATOR
Intervention: Placebo for vitamin C
Number of subjects: 14236
Study 20303119 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg solifenacin once daily
Number of subjects: 132
Study 20303119 — intervention group
Group type: COMPARATOR
Intervention: 5 mg oxybutynin immediate release 3 times daily
Number of subjects: 132
Study 17414988 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injection (ESI)
Number of subjects: 84
Study 15726875 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine (50 mg tablets, four times daily for three weeks)
Number of subjects: 40
Study 15726875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15726875 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 40
Study 12193488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilioinguinal-iliohypogastric nerve block with bupivacaine
Number of subjects: 0
Study 12193488 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infiltration)
Number of subjects: 0
Study 9660258 — intervention group
Group type: EXPERIMENTAL
Intervention: Gram-negative intestinal colonization
Number of subjects: 90
Study 9660258 — intervention group
Group type: EXPERIMENTAL
Intervention: Gram-negative colonization of the rectum
Number of subjects: 90
Study 9660258 — intervention group
Group type: EXPERIMENTAL
Intervention: Gram-negative colonization of the oropharynx
Number of subjects: 90
Study 7906327 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm heart surgery (37 degrees C cardioplegia with systemic normothermia)
Number of subjects: 1732
Study 7906327 — intervention group
Group type: COMPARATOR
Intervention: Cold heart surgery (hypothermic surgery)
Number of subjects: 1732
Study 7906327 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm heart surgery
Number of subjects: 1732
Study 7906327 — intervention group
Group type: COMPARATOR
Intervention: Cold heart surgery
Number of subjects: 1732
Study 2567670 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (M, 100 mg)
Number of subjects: 30
Study 2567670 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (P, 10 mg)
Number of subjects: 30
Study 30229693 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis cohort
Number of subjects: 3
Study 30229693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis cohort
Number of subjects: 3
Study 30229693 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplant wait-list cohort
Number of subjects: 3
Study 28202699 — intervention group
Group type: EXPERIMENTAL
Intervention: Single infarction with ICAS
Number of subjects: 1089
Study 28202699 — intervention group
Group type: EXPERIMENTAL
Intervention: Single infarction without ICAS
Number of subjects: 1089
Study 28202699 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple infarctions with ICAS
Number of subjects: 1089
Study 28202699 — intervention group
Group type: COMPARATOR
Intervention: No infarction or ICAS
Number of subjects: 1089
Study 25155428 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 (Sr-89)
Number of subjects: 79
Study 25155428 — intervention group
Group type: COMPARATOR
Intervention: Control arm (ADT, doxorubicin, and zoledronic acid)
Number of subjects: 79
Study 23246919 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer reproductive period (time between menarche and menopause)
Number of subjects: 126
Study 23246919 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous hormone therapy (HT) use
Number of subjects: 126
Study 21955700 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV) therapy
Number of subjects: 59
Study 21955700 — intervention group
Group type: COMPARATOR
Intervention: Non-ASV treatment (control group)
Number of subjects: 59
Study 21955700 — intervention group
Group type: EXPERIMENTAL
Intervention: ASV therapy
Number of subjects: 59
Study 19212427 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF-adenoviral
Number of subjects: 103
Study 19212427 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF-plasmid/liposome
Number of subjects: 103
Study 19212427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 16087353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 28
Study 16087353 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (WG)
Number of subjects: 28
Study 14567905 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centred approach to care with guidebooks on ulcerative colitis and Crohn's disease, including a written self-management plan and self-referral to services.
Number of subjects: 700
Study 9121225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 75
Study 9121225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 75
Study 1527231 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment
Number of subjects: 8
Study 1527231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2882773 — intervention group
Group type: EXPERIMENTAL
Intervention: temelastine 100 mg
Number of subjects: 12
Study 2882773 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 31714393 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation (CR) plus usual care
Number of subjects: 142
Study 31714393 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 142
Study 31974881 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetically Controlled Growing Rods (MCGRs) with a lengthening interval of 6 weeks
Number of subjects: 0
Study 31974881 — intervention group
Group type: COMPARATOR
Intervention: Magnetically Controlled Growing Rods (MCGRs) with a lengthening interval of 16 weeks
Number of subjects: 0
Study 26712942 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical DFMO applied twice daily
Number of subjects: 156
Study 26712942 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac applied daily
Number of subjects: 156
Study 26712942 — intervention group
Group type: EXPERIMENTAL
Intervention: DFMO plus diclofenac
Number of subjects: 156
Study 24823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive group therapy combined with pharmacotherapy
Number of subjects: 36
Study 24823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Happiness training combined with pharmacotherapy
Number of subjects: 36
Study 24823430 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy only
Number of subjects: 36
Study 23177226 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with incorporated expiratory manoeuvres
Number of subjects: 34
Study 23177226 — intervention group
Group type: COMPARATOR
Intervention: Breathing techniques
Number of subjects: 34
Study 20508081 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro protamine suspension (ILPS) 0.6 U/kg
Number of subjects: 0
Study 20508081 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 0.6 U/kg
Number of subjects: 0
Study 20508081 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro protamine suspension (ILPS)
Number of subjects: 0
Study 20508081 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0
Study 17880992 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between a desirable object and an undesirable object
Number of subjects: 0
Study 17880992 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between a desirable object and an empty location
Number of subjects: 0
Study 17880992 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent trials with the second object removed and the empty location reintroduced
Number of subjects: 0
Study 15802149 — intervention group
Group type: COMPARATOR
Intervention: Home cancer healthcare program
Number of subjects: 67
Study 15802149 — intervention group
Group type: COMPARATOR
Intervention: Home cancer healthcare program (palliative care)
Number of subjects: 67
Study 15802149 — intervention group
Group type: COMPARATOR
Intervention: Home cancer healthcare program (chemotherapy)
Number of subjects: 67
Study 12242586 — intervention group
Group type: COMPARATOR
Intervention: Standard term formula (SF)
Number of subjects: 33
Study 12242586 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched formula (PDF)
Number of subjects: 33
Study 12242586 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SF and PDF
Number of subjects: 33
Study 9952143 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 36
Study 9952143 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube
Number of subjects: 36
Study 7551935 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus surgery
Number of subjects: 44
Study 7551935 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 44
Study 2252966 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 24
Study 2252966 — intervention group
Group type: COMPARATOR
Intervention: Day treatment
Number of subjects: 24
Study 7358211 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (4.8 g per day for 4 days and 7.2 g on the 5th day)
Number of subjects: 12
Study 7358211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31668556 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet cupping therapy (WCT) applied once a month for 12 months (Group 2)
Number of subjects: 109
Study 31668556 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 1) received three sessions of WCT
Number of subjects: 109
Study 31237322 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dairy diet (HDD) (6 or 5 reduced-fat dairy portions for men and women, respectively)
Number of subjects: 52
Study 31237322 — intervention group
Group type: COMPARATOR
Intervention: Low-dairy diet (LDD) (≤1 dairy portion per day)
Number of subjects: 52
Study 29065491 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Standard Preparedness
Number of subjects: 16
Study 29065491 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Resilience approach
Number of subjects: 16
Study 25557762 — intervention group
Group type: EXPERIMENTAL
Intervention: rabbit antithymocyte globulin (rATG)
Number of subjects: 200
Study 25557762 — intervention group
Group type: COMPARATOR
Intervention: interleukin 2 receptor antagonists (IL‐2RA)
Number of subjects: 200
Study 23987161 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 50
Study 23987161 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 50
Study 22080012 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stress (normal vaccination+LPS)
Number of subjects: 540
Study 22080012 — intervention group
Group type: EXPERIMENTAL
Intervention: CPM stress (normal vaccination+CPM)
Number of subjects: 540
Study 22080012 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal vaccination (simplified vaccination + second dose of ND‐IB, H120, and AI)
Number of subjects: 540
Study 22080012 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified vaccination (H120, AI, NDV, ND‐IB)
Number of subjects: 540
Study 22080012 — intervention group
Group type: EXPERIMENTAL
Intervention: No vaccination
Number of subjects: 540
Study 22080012 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 540
Study 18363763 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with itch nursing programme
Number of subjects: 56
Study 18363763 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 56
Study 16434755 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate salts (PO)
Number of subjects: 40
Study 16434755 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PG)
Number of subjects: 40
Study 16807618 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg tablet once daily for 10 weeks
Number of subjects: 195
Study 11050522 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 164
Study 11050522 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 164
Study 10096415 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal span tasks
Number of subjects: 0
Study 10096415 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial span tasks
Number of subjects: 0
Study 10096415 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 8262292 — intervention group
Group type: EXPERIMENTAL
Intervention: Amox‐CA (Augmentin) 1.2 g intravenous injection, 1 hour after delivery
Number of subjects: 1291
Study 8262292 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 1291
Study 3513943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and Doxorubicin (CA)
Number of subjects: 440
Study 3513943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, Doxorubicin and Cisplatin (CAP)
Number of subjects: 440
Study 29274949 — intervention group
Group type: EXPERIMENTAL
Intervention: Habituation of eating desires
Number of subjects: 52
Study 29274949 — intervention group
Group type: EXPERIMENTAL
Intervention: Violation of overeating expectancies
Number of subjects: 52
Study 29274949 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 52
Study 29274949 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cue exposure conditions
Number of subjects: 52
Study 26690319 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 407
Study 26690319 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (DP-EES)
Number of subjects: 407
Study 26690319 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 407
Study 24447187 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized streetside training
Number of subjects: 231
Study 24447187 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in a virtual pedestrian environment
Number of subjects: 231
Study 24447187 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos and websites training
Number of subjects: 231
Study 24447187 — intervention group
Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 231
Study 24447187 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (including control)
Number of subjects: 231
Study 22633601 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% energy from fat)
Number of subjects: 48835
Study 22633601 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 48835
Study 20338292 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-carbohydrate diet (4% total energy as carbohydrate, 35% protein, 61% fat)
Number of subjects: 68
Study 20338292 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (46% total energy as carbohydrate, 24% protein, 30% fat)
Number of subjects: 68
Study 18390558 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated fractionation radiation therapy (2.4 Gy/fr)
Number of subjects: 360
Study 18390558 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation radiation therapy (2 Gy/fr)
Number of subjects: 360
Study 15988102 — intervention group
Group type: COMPARATOR
Intervention: cilostazol + aspirin (C group)
Number of subjects: 642
Study 15988102 — intervention group
Group type: EXPERIMENTAL
Intervention: ticlopidine + aspirin (T group)
Number of subjects: 642
Study 12820029 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless Lichtenstein (group 2)
Number of subjects: 46
Study 12820029 — intervention group
Group type: COMPARATOR
Intervention: Classical Lichtenstein (group 1)
Number of subjects: 46
Study 10774681 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination regimens of artemether/pyrimethamine (1‐, 2‐ and 3‐day regimens)
Number of subjects: 0
Study 10774681 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plasma PYR concentrations
Number of subjects: 0
Study 8724908 — intervention group
Group type: EXPERIMENTAL
Intervention: Sung lyrics (musical accompaniment)
Number of subjects: 20
Study 8724908 — intervention group
Group type: COMPARATOR
Intervention: Read aloud lyrics (no musical accompaniment)
Number of subjects: 20
Study 1649863 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction and sodium restriction (diet group)
Number of subjects: 61
Study 1649863 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (antihypertensive drug treatment group)
Number of subjects: 61
Study 1649863 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 61
Study 6858934 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirmenol (50 mg priming bolus over 2 minutes, followed by 2.5 mg/min for 1 hour, and 0.25 mg/min maintenance infusion)
Number of subjects: 8
Study 6858934 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirmenol
Number of subjects: 8
Study 6858934 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study 31405799 — intervention group
Group type: EXPERIMENTAL
Intervention: Struggle-First (SF) condition
Number of subjects: 42
Study 31405799 — intervention group
Group type: COMPARATOR
Intervention: Teach-First (TF) condition
Number of subjects: 42
Study 29166695 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Spitzy suture in children
Number of subjects: 476
Study 29166695 — intervention group
Group type: COMPARATOR
Intervention: Direct suture in adults (control group)
Number of subjects: 476
Study 27957632 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drug (AED) treatment
Number of subjects: 42
Study 27957632 — intervention group
Group type: COMPARATOR
Intervention: Non-AED treatment (Control)
Number of subjects: 42
Study 27957632 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with subcortical calcifications (AED treatment)
Number of subjects: 42
Study 27957632 — intervention group
Group type: COMPARATOR
Intervention: Subgroup analysis of patients with subcortical calcifications (Control)
Number of subjects: 42
Study 26821625 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone, 6.25 mg daily
Number of subjects: 54
Study 26821625 — intervention group
Group type: COMPARATOR
Intervention: HCTZ, 12.5 mg daily
Number of subjects: 54
Study 26821625 — intervention group
Group type: COMPARATOR
Intervention: HCTZ-CR, 12.5 mg daily
Number of subjects: 54
Study 24555925 — intervention group
Group type: EXPERIMENTAL
Intervention: 42 °C warm water for 20 min
Number of subjects: 27
Study 24555925 — intervention group
Group type: COMPARATOR
Intervention: 15 °C cold water for 20 min
Number of subjects: 27
Study 24555925 — intervention group
Group type: COMPARATOR
Intervention: Baseline condition at room temperature
Number of subjects: 27
Study 23405799 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangjing Capsule (5 pills, tid) plus low-dose tadalafil (5 mg, qd, 1 h before bedtime)
Number of subjects: 55
Study 23405799 — intervention group
Group type: COMPARATOR
Intervention: Oral ephedrine (25 mg before bedtime)
Number of subjects: 55
Study 19580356 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleassistance system using real-time transmission of blood glucose results and telephone consultations
Number of subjects: 328
Study 19580356 — intervention group
Group type: COMPARATOR
Intervention: Regular follow-up at healthcare center (Control)
Number of subjects: 328
Study 17503670 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg Suc-HSA (single dose)
Number of subjects: 10
Study 17503670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg Suc-HSA (single dose)
Number of subjects: 10
Study 17503670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg Suc-HSA (multiple doses)
Number of subjects: 10
Study 17503670 — intervention group
Group type: COMPARATOR
Intervention: N/A (control not specified)
Number of subjects: 10
Study 15613683 — intervention group
Group type: COMPARATOR
Intervention: Old volunteers
Number of subjects: 22
Study 12470517 — intervention group
Group type: EXPERIMENTAL
Intervention: 585 nm laser treatment at subpurpura energy level
Number of subjects: 0
Study 12470517 — intervention group
Group type: EXPERIMENTAL
Intervention: Second treatment with 585 nm laser 2 weeks later
Number of subjects: 0
Study 12470517 — intervention group
Group type: COMPARATOR
Intervention: Broadband, pulsed, white light source at 4 J/cm(2)
Number of subjects: 0
Study 12470517 — intervention group
Group type: COMPARATOR
Intervention: Broadband, pulsed, white light source at 7 J/cm(2)
Number of subjects: 0
Study 9638854 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ATG (total dose 484 +/- 110 mg, 0.75 mg/kg per day)
Number of subjects: 60
Study 9638854 — intervention group
Group type: COMPARATOR
Intervention: Low-dose OKT3 (total dose 32 +/- 4 mg, 0.05 mg/kg per day)
Number of subjects: 60
Study 9638854 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ATG
Number of subjects: 60
Study 9638854 — intervention group
Group type: COMPARATOR
Intervention: Low-dose OKT3
Number of subjects: 60
Study 9638854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ATG and OKT3
Number of subjects: 60
Study 7990322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgical debridement
Number of subjects: 0
Study 2648839 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 gm of calcium supplementation a day
Number of subjects: 34
Study 2648839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 29803204 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate eccentric cadence (REG) 2/0/2/0
Number of subjects: 16
Study 29803204 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow eccentric cadence (SLOW) 6/0/2/0
Number of subjects: 16
Study 29803204 — intervention group
Group type: COMPARATOR
Intervention: Both protocols (SLOW and REG)
Number of subjects: 16
Study 28162127 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly food voucher of $US 40
Number of subjects: 4343
Study 28162127 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly food voucher of $US 40 plus training on health and nutrition
Number of subjects: 4343